Autosomal dominant polycystic kidney disease (ADPKD) is the most common hereditary cause of chronic kidney disease stage 5 and represents 3% to 10.3% among patients undergoing dialysis in Brazil. The ADPKD is caused by mutations in one of two genes, PKD1 or PKD2 encoding hence the polycystins 1 and 2 involved in cyst formation. The disease is characterized by progressive growth and development of multiple bilateral renal cysts which lead to loss of kidney function. The ADPKD presents several renal and extrarenal clinical manifestations, and comorbidities. Some diagnostic strategies are regarded as first choice for clinical and molecular investigation of the ADPKD. The knowledge of molecular aspects in association with the clinical manifestations presented by the epidemiology of the disease provides better understanding of the mechanisms of cystogenesis and greater diagnostic accuracy